Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Deep Track Capital Holds 6M Nurix Shares at 5.49%

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin filed Amendment No. 4 to their Schedule 13G with the SEC on November 16, 2026, disclosing a combined beneficial ownership position in Nurix Therapeutics, Inc. common stock as of September 30, …

Shwetambri Chauhan | 16 November 2026

Deep Track Reports 15M Shares in Structure Therapeutics

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin filed Amendment No. 5 to Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership of common shares in Structure Therapeutics Inc. as of September 30, 2026.

Shwetambri Chauhan | 16 November 2026

Iroquois Capital Files Amended 13G on SCWorx, Holds 9.99%

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page filed Amendment No. 7 to a Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership of common stock in SCWorx Corp. as of September 30, 2026.

Nitish Kishor | 16 November 2026

Iroquois Group Reports 7.93% Stake in Auddia Inc.

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership positions in Auddia Inc. (NASDAQ:AUUD) as of September 30, 2026.

Anjali Anand | 16 November 2026

Corebridge Reports 9.5% Stake in Carlyle Tactical Private Credit Fund

Corebridge Financial, Inc. filed Amendment No. 3 to Schedule 13G on November 16, 2026, disclosing beneficial ownership of 4,000,000 shares, representing 9.5% of the outstanding securities of Carlyle Tactical Private Credit Fund as of September 30, 2026.

Nitish Kishor | 16 November 2026

Highbridge Discloses 5.8% Warrant-Based Stake in TOYO

Highbridge Capital Management, LLC filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 2,619,799 ordinary shares of TOYO Co., Ltd (NASDAQ:TOYO), representing 5.8% of the outstanding class, with all shares issuable upon exercise of warrants held by …

Nitish Kishor | 16 November 2026

Highbridge Discloses 5.3% Stake in Quantum Leap Acquisition

Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of Class A Ordinary Shares of Quantum Leap Acquisition Corp as of the triggering event date of September 30, 2026.

Shwetambri Chauhan | 16 November 2026

Highbridge Discloses 5.3% Stake in AA Mission Acquisition II

Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 629,816 Class A Ordinary Shares of AA Mission Acquisition Corp. II, a Cayman Islands exempted company, as of the triggering event date of September 30, …

Vinay Lochav | 16 November 2026

Stonepine Discloses 8.1% Stake in CalciMedica at Sept. 30

Stonepine Capital Management, LLC and related reporting persons filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 579,912 shares of CalciMedica, Inc. common stock as of September 30, 2026.

Manish Choudhary | 16 November 2026

Highbridge Reports 7% Stake in Starlink AI Acquisition

Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing a 7.0% beneficial ownership position in the ordinary shares of Starlink AI Acquisition Corporation as of September 30, 2026.

Aditi Sarkar | 16 November 2026
Support

Hi! How can we help you today?

Loading…